Novopen Echo FAQs
How much does Novopen Echo cost without insurance?
If you don't have insurance, you could end up paying as much as $80.81 for Novopen Echo. To reduce your expense you could use a SingleCare prescription discount card with your Novopen Echo purchase. When you use our savings card, you pay our lowest price of $54.81 for 1, 1 device box of Novopen Echo at checkout at any participating pharmacy in the United States.
How much does Novopen Echo cost with insurance?
The cost of Novopen Echo with insurance can vary by insurance plan. However, your pharmacist can help you to calculate the cost for Novopen Echo as well as your copay. With a SingleCare discount card you could pay $54.81 for 1, 1 device box of Novopen Echo which may be less expensive than your insurance. You can also ask your pharmacist to help you compare prices to find the best price for Novopen Echo for you.
Does Medicare cover Novopen Echo and how much does it cost?
Novopen Echo is covered by some Medicare plans but if you are still looking to save money on the cost of Novopen Echo you can with SingleCare. When you use a SingleCare Novopen Echo coupon, you could pay the discounted price of $54.81 for 1, 1 device box of Novopen Echo. You can redeem your automatic savings at a participating pharmacy such as CVS, Target, Walmart, or Walgreens near you.
Is there a generic of Novopen Echo?
Novopen Echo is a reusable insulin injector pen with dose memory that tells you how many units were injected and the time since the last dose. This device may be used by adults and children with Type 2 diabetes. Currently, there is no generic version of Novopen Echo available in the U.S. market. The average retail price of Novopen Echo is about $80.81. If you are looking for a way to save on the price of Novopen Echo you can with a SingleCare Novopen Echo coupon. With our discount card you could pay $54.81 for 1, 1 device box of Novopen Echo at your local pharmacy.
What is Novopen Echo?
Novopen Echo is the first-ever reusable insulin injector pen with dose memory that tells you how many units were injected and the time since the last dose. This device may be used by adults and children with Type 2 diabetes. Novopen Echo also offers fine-tuned dosing in half-unit increments. This single patient-use pen injector uses Penfill cartridges of Novo Nordisk insulin. It is also compatible with single-use disposable needles such as NovoFine, NovoTwist, NovoFine Plus, and NovoFine Autocover. Novopen Echo also has a robust design that is built to last up to five years.
Do not use your Novopen Echo if you are not sure about its usage instructions. You can find detailed about Type 1 and Type 2 diabetes care, important safety information, and a user's guide at the Novopen Echo website.
Before using Novopen Echo check with your healthcare provider to see if this device is right for you or your child. If you have other medical conditions or if you are using other treatments tell your doctor before you start using Novopen Echo with insulin. Remember to always monitor your blood sugar as recommended by your doctor.
Only use Novopen Echo with insulin as recommended by your doctor. Do not use more or less than your prescribed dose of insulin as this could lead to serious adverse reactions. Always supervise children using this device. Novopen Echo is meant to be used by one patient. Do not share this device or needles as this could cause the spread of known or unknown infections. Remember to change your injector pen needles as necessary. Always dispose of your needles properly or under the guidelines recommended for medical waste disposal.
Keep Novopen Echo out of the reach of children and pets.
What are the side effects of Novopen Echo?
There are no listed side effects associated with using Novopen Echo insulin delivery device. However, if you have any concerns you can contact your healthcare provider or the makers of Novopen Echo for clarification.
This is not a complete list of the possible list of side effects of Novopen Echo and others may occur. You may also report any side effects to the FDA.
